# ASRTAVA Laboratory Information System (LIS) Audit & Gap Analysis

**Audit Date:** 2026-11-09  
**System Version:** ASRTAVA v1.9.0  
**Auditor:** ASRTAVA Lead Clinical Systems Architect & Pathologist Informatics Specialist  
**Scope:** Inspect existing database entities, routes, services, and frontend workspaces relating to Laboratory Diagnostics, Specimen Collection, Analyzer Telemetry, Results, Microbiology, Quality Control, and Reporting.

---

## 1. Executive Summary

ASRTAVA featured initial laboratory tables in `009_laboratory_radiology.sql` (`lab_test_catalog`, `lab_orders`, `lab_order_items`, `lab_samples`, `lab_results`) and a baseline route file `backend/src/modules/diagnostics/diagnostics.routes.ts`. Additionally, in Milestone 16 (`022_healthcare_interoperability_and_medical_devices.sql`), an ASTM 1394-97 frame parser and device telemetry gateway was introduced.

However, clinical hospital laboratories require an end-to-end, multi-departmental Laboratory Information System (LIS) capable of managing the complete specimen lifecycle, quality assurance, microbiology culture workflows, and pathologist authorization gates:
1. **Departmental Specialization:** Prior implementation lacked formal departmental segregation across Clinical Biochemistry, Haematology, Clinical Pathology, Microbiology, Histopathology, Cytology, and Immunology.
2. **Granular Multi-Parameter Profiles:** Tests were flat entities rather than multi-analyte profiles (e.g. Complete Blood Count requiring 18 parameters with differential percentages).
3. **Age & Sex Bio-Reference Ranges:** Reference ranges were static rather than dynamically matched to patient age, gestational status, and sex.
4. **Specimen Accessioning & Barcode Integrity:** No accessioning engine generating unique 2D barcode labels with container color codes (Lavender EDTA, Red/Gold Serum Gel, Light Blue Sodium Citrate, Grey Sodium Fluoride).
5. **Specimen Rejection & Recollection Workflow:** Rejections lacked structured root-cause logging (Hemolyzed, Clotted, QNS, Wrong Container) and automated phlebotomy recollection ticketing.
6. **Two-Tier Validation Gate:** Results could not distinguish between medical technologist technical validation and consulting pathologist medical sign-off.
7. **Microbiology Cultures & AST:** Zero support for bacterial cultures, colony counts, and antibiotic susceptibility testing (AST).
8. **Internal Quality Control (IQC):** No Levey-Jennings control charting or Westgard rule evaluation engine ($1_{2s}, 1_{3s}, 2_{2s}, R_{4s}, 10_{\bar{x}}$).
9. **Critical Value Escalation:** Absence of a dedicated panic-value notification and clinical acknowledgment ledger.

---

## 2. Existing Laboratory Entities & Reuse Strategy

| Existing Entity | Defined In | Reuse Strategy |
| :--- | :--- | :--- |
| `lab_test_catalog` | `009_laboratory_radiology.sql` | Retain as high-level catalog; link to expanded multi-parameter tables. |
| `lab_orders` | `009_laboratory_radiology.sql` | Retain for order header linkage with billing and doctor encounters. |
| `lab_order_items` | `009_laboratory_radiology.sql` | Link to specimen collection accession numbers. |
| `device_telemetry_logs` | `022_healthcare_interoperability.sql` | Reused for direct serial/socket ASTM analyzer message intake. |
| `inpatient_billing_invoices` | `010_billing_finance.sql` | Direct financial clearance linkage without duplicate billing. |

---

## 3. Architecture Blueprint for LIS v1.10.0

The modern LIS connects doctors, phlebotomists, medical laboratory technologists, senior pathologists, and patients through a unified, auditable transaction chain backed by `database/migrations/026_complete_laboratory_information_system.sql`.

